Sensitive high-performance liquid chromatographic assay for motexafin gadolinium and motexafin lutetium in human plasmaPARISE, Robert A; MILES, Dale R; EGORIN, Merrill J et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 749, Num 2, pp 145-152, issn 1387-2273Article

Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte culturesKOMOROSKI, Bernard J; PARISE, Robert A; EGORIN, Merrill J et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 6972-6979, issn 1078-0432, 8 p., 1Article

A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serumPARISE, Robert A; HOLLERAN, Julianne L; BEUMER, Jan H et al.Journal of chromatography. B. 2006, Vol 840, Num 2, pp 108-115, issn 1570-0232, 8 p.Article

Disposition of imatinib and its metabolite CGP74588 in a patient with chronic myelogenous leukemia and short-bowel syndromeBEUMER, Jan H; NATALE, James J; LAGATTUTA, Theodore E et al.Pharmacotherapy. 2006, Vol 26, Num 7, pp 903-907, issn 0277-0008, 5 p.Article

Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasmaPARISE, Robert A; RAMANATHAN, Ramesh K; HAYES, Michael J et al.Journal of chromatography. B. 2003, Vol 791, Num 1-2, pp 39-44, issn 1570-0232, 6 p.Article

Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasmaPARISE, Robert A; RAMANATHAN, Ramesh K; ZAMBONI, William C et al.Journal of chromatography. B, Biomedical sciences and applications. 2003, Vol 783, Num 1, pp 231-236, issn 1387-2273, 6 p.Article

Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerasePARISE, Robert A; SHAWAQFEH, Mohammad; EGORIN, Merrill J et al.Journal of chromatography. B. 2008, Vol 872, Num 1-2, pp 141-147, issn 1570-0232, 7 p.Article

CASE 4. Pulmonary stent migration and ingestion in a lung cancer patientBROWN, Jason W; CHRISTIE, Neil A; EVANS, Carol et al.Journal of clinical oncology. 2006, Vol 24, Num 9, pp 1478-1479, issn 0732-183X, 2 p.Article

Physiologically-based pharmacokinetics and molecular pharmacodynamics of 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite in tumor-bearing miceLU XU; EISEMAN, Julie L; EGORIN, Merrill J et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2003, Vol 30, Num 3, pp 185-219, issn 1567-567X, 35 p.Article

Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detectionBEUMER, Jan H; JOSEPH, Erin; EGORIN, Merrill J et al.Journal of chromatography. B. 2006, Vol 831, Num 1-2, pp 147-155, issn 1570-0232, 9 p.Article

Normal-phase and stability-indicating reversed-phase high-performance liquid chromatographic methods for the determination of the novel antitumor agent : 1-methylpropyl-2-imidazolyldisulfideHASHASH, Ahmad; KIRKPATRICK, D. Lynn; EGORIN, Merrill J et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 768, Num 2, pp 239-246, issn 1387-2273Article

A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in miceBEUMER, Jan H; JOSEPH, Erin; EGORIN, Merrill J et al.Clinical cancer research. 2006, Vol 12, Num 19, pp 5826-5833, issn 1078-0432, 8 p.Article

Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in miceBEUMER, Jan H; EISEMAN, Julie L; PARISE, Robert A et al.Clinical cancer research. 2006, Vol 12, Num 24, pp 7483-7491, issn 1078-0432, 9 p.Article

Limited penetration of anticancer drugs through tumor tissue: A Potential cause of resistance of solid tumors to chemotherapyTANNOCK, Ian F; LEE, Carol M; TUNGGAL, Jonathon K et al.Clinical cancer research. 2002, Vol 8, Num 3, pp 878-884, issn 1078-0432Article

Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenograftsZAMBONI, William C; STRYCHOR, Sandra; JOSEPH, Erin et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 3, pp 417-426, issn 0344-5704, 10 p.Article

Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma linesPARISE, Robert A; ANYANG, Bean N; EISEMAN, Julie L et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 73-83, issn 0344-5704, 11 p.Article

Imatinib mesylate efficiently achieves Therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancerWOLFF, Nicholas C; RANDLE, Dwight E; EGORIN, Merrill J et al.Clinical cancer research. 2004, Vol 10, Num 10, pp 3528-3534, issn 1078-0432, 7 p.Article

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerBEER, Tomasz M; EILERS, Kristine M; GARZOTTO, Mark et al.Journal of clinical oncology. 2003, Vol 21, Num 1, pp 123-128, issn 0732-183X, 6 p.Article

Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1EGORIN, Merrill J; ZUHOWSKI, Eleanor G; ROSEN, D. Marc et al.Cancer chemotherapy and pharmacology. 2001, Vol 47, Num 4, pp 291-302, issn 0344-5704Article

A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patientsHEBB, Jonathan; ASSOULINE, Sarit; ROUSSEAU, Caroline et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 3, pp 643-651, issn 0344-5704, 9 p.Article

Effect of antacid on imatinib absorptionSPARANO, Brian A; EGORIN, Merrill J; PARISE, Robert A et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 3, pp 525-528, issn 0344-5704, 4 p.Article

Imatinib Mesylate Pharmacokinetics Before and After Sleeve Gastrectomy in a Morbidly Obese Patient with Chronic Myeloid LeukemiaPAVLOVSKY, Carolina; EGORIN, Merrill J; SHAH, Dhvani D et al.Pharmacotherapy. 2009, Vol 29, Num 9, pp 1152-1156, issn 0277-0008, 5 p.Article

Modulation of Gemcitabine (2',2'-Difluoro-2'-Deoxycytidine) Pharmacokinetics, Metabolism, and Bioavailability in Mice by 3,4,5,6-TetrahydrouridineBEUMER, Jan H; EISEMAN, Julie L; PARISE, Robert A et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3529-3535, issn 1078-0432, 7 p.Article

Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primatesKERR, Jody Z; BERG, Stacey L; DAUSER, Robert et al.Cancer chemotherapy and pharmacology. 2001, Vol 47, Num 5, pp 411-414, issn 0344-5704Article

Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD₂F₁ mice and Fischer 344 ratsSTECKLAIR, Kataleeya P; HAMBURGER, Deborah R; EGORIN, Merrill J et al.Cancer chemotherapy and pharmacology. 2001, Vol 48, Num 5, pp 375-382, issn 0344-5704Article